---
schema_version: "secwatch.filing_event.v1"
accession: "0001606498-25-000126"
form_type: "8-K"
ticker: "AVNS"
cik: "0001606498"
company_name: "AVANOS MEDICAL, INC."
filed_at: "2025-10-23T23:59:59+00:00"
generated_at: "2026-05-17T02:30:41.231590+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Avanos eliminates Chief Commercial Officer and General Counsel positions; two executives to leave Dec 1

## Summary
- Kerr Holbrook (CCO) and Mojirade James (General Counsel & Secretary) terminated effective Dec 1, 2025 due to position elimination in restructuring.
- Severance: Holbrook ~$1.54M, James ~$1.43M, plus 12 months COBRA premium coverage.
- Unvested equity: time-based RSUs vest pro rata; performance-based RSUs vest at end of period; stock options exercisable for 5 years.
- Prorated 2025 bonuses at target approved for both executives.
- Payments conditional on separation agreement, general release, and continued compliance with confidentiality/non-solicitation.

## SEC filing metadata
- accession: 0001606498-25-000126
- form_type: 8-K
- ticker: AVNS
- cik: 0001606498
- company_name: AVANOS MEDICAL, INC.
- filed_at: 2025-10-23T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1606498/000160649825000126/0001606498-25-000126-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1606498/000160649825000126/avns-20251021.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001606498-25-000126
- JSON: https://secwatch.observer/filing/0001606498-25-000126.json
- Plain text: https://secwatch.observer/filing/0001606498-25-000126.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.